The best shampoo for hair loss is usually a cheap one, and it is not the point

The best shampoo for hair loss, for most people asking, is a mild one you already own — plus an appointment to find out what is actually going on. That answer pays this site nothing, which is exactly why it goes first. Everything below is the aisle graded honestly against its own evidence, and the honest summary is that no shampoo is approved in the United States as a hair grower and nothing here scores higher than seven out of ten.

Start with the thing that pays nobody

Hair thins for reasons a bottle cannot reach. Thyroid disease, low iron, telogen effluvium in the months after an illness or a birth, alopecia areata, scarring alopecias and the side effects of medicines you already take all shed hair, and a shampoo treats none of them. A GP or a board-certified dermatologist can tell them apart, usually with a history and a blood test. That visit pays us nothing and it is still the first thing we would do.

If you also have flaking, itching or an oily, irritated scalp, treat that on its own terms. An over-the-counter anti-dandruff shampoo says on its own label what it is for, costs a few pounds in any supermarket, and — as the grade book below shows — the two medicated shampoo actives with the strongest trials in this whole aisle happen to be exactly the two sold that way. Neither of those purchases pays us a penny.

Only after that does the question "which product" become worth money. If you want the leave-on half of the aisle instead, the same scale is applied to droppers and oils on the best hair growth serum, graded the same way.

How a grade is built here

Every active gets ten points, split across four questions, and the split is published so you can disagree with it. A star rating would hide the only thing worth knowing: not how good an ingredient is, but how much is actually known about it.

1. Trials in hair loss, worth four points. None we could find scores zero; an uncontrolled study or one compared only against another active treatment scores one; one placebo- or untreated-controlled trial scores two; more than one scores three; more than one, run independently of the seller and agreeing, scores four.
2. Who paid for them, worth two. The seller or the ingredient's maker scores zero, unstated or mixed funding scores one, funding independent of the seller scores two.
3. What was counted, worth two. Self-report or photographs score zero, an investigator's rating or a hair-pull test scores one, hairs actually counted or measured score two.
4. Whether the shelf product matches the trial, worth two. This is the question the aisle relies on you not asking, and it is where most marketing lives.

Eight to ten means as good as this aisle gets; five to seven means mixed, with real caveats; three to four is thin; nought to two means nothing published we could find. An active we could not read at the source gets no grade at all rather than a borrowed one, and its row says so. Nothing in the table below reaches eight.

The grade book

Pyrithione zinc: the best-designed trial in the aisle is on a dandruff shampoo

Pyrithione zinc 1% scores 7/10, the highest grade on this site, and it is sold as ordinary anti-dandruff shampoo. Berger and colleagues randomised 200 men to a 1% pyrithione zinc shampoo, a 5% minoxidil solution, both together, or a placebo shampoo, and counted total visible hairs with fibre-optic microscopy over 26 weeks. The shampoo beat the placebo shampoo from nine weeks and held it; the increase was slightly less than half the increase seen on minoxidil, and combining the two added nothing (British Journal of Dermatology, 2003).

That is a real controlled trial, on the product you can actually buy, counting hairs rather than asking people how they felt. It loses points on funding — the authors wrote from a contract research organisation and the trial's sponsor is not stated in the abstract — and it is one trial from 2003. Notably, the 2025 Canadian expert consensus on androgenetic alopecia does not list pyrithione zinc among either its recommended or its not-recommended interventions, so nobody should read this grade as an endorsement by anyone but us.

Ketoconazole: the strength that was studied is not the strength on the shelf

Ketoconazole 1% (2% on prescription) scores 6/10, and the gap inside that name is the whole story. Piérard-Franchimont and colleagues compared a 2% ketoconazole shampoo with an unmedicated shampoo, with and without minoxidil, and reported hair density, hair size and the proportion of anagen follicles improving almost similarly on ketoconazole and on minoxidil — while writing plainly that the clinical significance awaited a larger controlled study (Dermatology, 1998). A 2020 systematic review in Dermatologic Therapy found five human studies with 318 participants between them and concluded that randomised controlled trials are still needed.

What you can buy without a prescription is 1%, not 2%, and its Drug Facts label makes no hair claim at all: it says it controls flaking, scaling and itching associated with dandruff. That mismatch costs it a point on the fourth question. The 2025 Canadian consensus places ketoconazole shampoo among interventions recommended with near consensus — as part of a regimen, not on its own. Full detail, and what the label does and does not permit anyone to say, is in what the ketoconazole shampoo evidence actually shows.

Caffeine: two trials, and the regulator that read them

Caffeine scores 4/10 — thin, and instructive about why. There is a double-blind trial of a phyto-caffeine shampoo against a control shampoo in women with androgenetic alopecia, whose primary endpoint was how many hairs came away in a pull test (Giornale Italiano di Dermatologia e Venereologia, 2020). And there is the famous one: 210 men, a 0.2% caffeine leave-on liquid against 5% minoxidil solution, reported as non-inferior (Skin Pharmacology and Physiology, 2017) — funded by Dr. Kurt Wolff, the company that sells Alpecin, with a company employee among the authors.

A leave-on liquid is not a shampoo, which costs the row on the fourth question, and a pull test is a cruder outcome than a hair count. The UK Advertising Standards Authority reached its own view on 28 March 2018, upholding a complaint against Dr Kurt Wolff GmbH and telling it not to state or imply the product could reduce hair loss without adequate evidence. The 2025 Canadian consensus lists caffeine among interventions it does not recommend. The longer reading is in the caffeine shampoo evidence, trial by trial.

Minoxidil in a shampoo: a zero, and the rule behind it

Minoxidil, in a shampoo scores 0/10, which is not an insult — it is the literal reading. A PubMed search for a trial of minoxidil delivered in a rinse-off shampoo returned nothing on 24 September 2026. The minoxidil the FDA cleared for sale without a prescription is a leave-on topical solution or foam, and a wash is in contact with the scalp for minutes before it goes down the drain.

There is a regulation behind this, and it is short. The FDA's own guidance states that a claim a product will restore hair growth makes it a drug rather than a cosmetic, and 21 CFR 310.527 — the final monograph of 7 July 1989 — holds that there is a lack of adequate data to establish general recognition of safety and effectiveness for over-the-counter hair growers, so any such product is a new drug requiring approval. That is why the bottle in your hand says "thicker-looking hair" and not "regrows hair". Why contact time decides what a shampoo can do goes through it properly. Prescription-only topicals are a matter for a prescriber, and this site does not cover them.

The two we would not grade

Saw palmetto, applied to the scalp appears in two 2025 reviews — Gupta and colleagues in Skin Appendage Disorders, and Bikash in the International Journal of Trichology — among the non-prescription actives that have published trials. We have not read those trials at the source, so it is not graded here. Borrowing a number from someone else's summary would look identical on the page and mean nothing.

Nanoxidil is the active in one seller's serum line. A PubMed search for the word returned no records on 24 September 2026, so there is nothing for this scale to read and it is not graded either. That is a statement about the published literature, not about whether the product does anything — and it applies to a company whose links appear further down this page, which is rather the point.

Where the shops come in, and what we could not find about them

Four sellers on this site are partner links. None of their own formulas holds a grade in the table above, for the reason just given: we could not read an independent controlled trial of one. We link them because people ask for them by name and would rather be told what is and is not known than be sent away.

DS Laboratories, for its Revita and Spectral lines

DS Laboratories sells shampoo, conditioner and the Spectral serums built on Nanoxidil, alongside a micro-needling roller. Its own site is careful in a way worth noticing: it says clients report visibly fuller hair over months, with a note that results vary and are not guaranteed, rather than claiming regrowth (read 24 September 2026).

Scandinavian Biolabs, for the topical routines

Scandinavian Biolabs sells a leave-on activation serum, a hairline product and a shampoo-and-conditioner routine; its bundles also include hair nutrient tablets, which are outside what this site covers. Its storefront answered in euros when we read it on 24 September 2026, and it prints figures such as "93% reduced hair loss in 150 days" directly on the page. Those are the company's own numbers from its own testing, not an independent trial, and we found no peer-reviewed trial of the product in PubMed.

Vegamour, for the plant-based serums

Vegamour sells serums, shampoos and conditioners under its GRO lines, plus supplements and a roller that fall outside this site. Its shedding claims carry a visible qualifier — based on consistent use for at least 90 days, individual results may vary — which is the honest shape of a cosmetic claim, and which is also not a hair-count trial.

Amazon, for the generic versions of what actually scored

The two best-graded actives on this site are generic and cheap, and a supermarket shelf is the least expensive place to find them. If you would rather not go out, they are ordinary catalogue items. We earn a rounding error on those, which is the closest thing to a free recommendation the internet allows.

What we would do, in order

1. See a doctor about the cause before spending anything. Pattern hair loss is a diagnosis, not a default.
2. Treat a flaking or itchy scalp with a medicated shampoo that says so on its label, generic and cheap.
3. Expect nothing dramatic. The best-evidenced shampoo in this aisle produced less than half the hair-count change of a leave-on drug in the one trial that compared them.
4. Judge a serum by the fourth question. Ask whether the trial used the product in the bottle, at that strength, left on the way you will leave it on.
5. Ignore before-and-after photographs, including ours — we publish none, because lighting, haircut and camera angle move a photograph further than any active here.